透過您的圖書館登入
IP:3.137.177.255
  • 期刊

化學治療引起之嗜中性球減少症合併高體溫

Chemotherapy-Induced Neutropenia Fever

摘要


判斷嗜中性球減少症病人是否出現感染,體溫升高是最重要指標,嗜中性球減少症合併高體溫可能快速發展進而威脅生命,因此需建立系統性評估與立即抗生素治療等處置原則以降低死亡率。群落刺激因子已被廣泛使用作為嗜中性球減少症病人的支持療法,目前已有許多文獻證實使用群落刺激因子作為初級預防性支持療法,可降低嗜中性球減少症合併高體溫發生率。有關嗜中性球減少症合併高體溫病人照護,腫瘤護理人員一直擔任關鍵角色,建議在預防與監測病人臨床表現、評估病人徵象與徵兆、評值照護成效與病人家屬衛教等方面,均應建立共通標準,以達到高品質照護目標。

並列摘要


Fever is the most important indicator for neutropenic patients with infection. Neutropenia fever can quickly develop and become life-threatening. In order to decreasing mortality, systematic assessment and initiative in using empirical antibiotic therapy need to be established. Colony-stimulating factors are recommended as supportive therapies for neutropenic patients. It is now well understood that primary prophylaxis with colony-stimulating factors treatment can reduce the incidence of neutropenia fever. Oncology nurses play a key role in nursing care of neutropenia fever. The recoomendations of this article are to set up nursing standards in preventing and monitoring patients' clinical performance, assessing patients' symptoms and signs, evaluating outcome and ensuring that patients and families education. It is essential and to achieve the goal of high quality care for neutropenic patients.

並列關鍵字

chemotherapy neutropenia neutropenia fever

延伸閱讀